Joshua Brody, MD

Joshua Brody, MD, is the Director of the Lymphoma Immunotherapy Program at The Tisch Cancer Institute at Mount Sinai and a faculty member of the Icahn Genomics Institute.

Articles by Joshua Brody, MD

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Approves Tucatinib Maintenance Regimen in HER2+ Metastatic Breast Cancer

Costa Explains What Drives Survival Benefit With Tec/Dara in Myeloma

SurVaxM Improves OS Only in Younger Subgroup in Newly Diagnosed Glioblastoma

Phase 2 Data Show PFS Benefit With Carotuximab Combo in mCRPC

c-Met ADC Temab-A Gains 2 FDA Breakthrough Designations in CRC, NSCLC